The global calcium gluconate market size is expected to increase USD 179.31 billion by 2033 from USD 98.72 billion in 2023 with a CAGR of 6.15% between 2024 and 2033.
Key Points
- The North America calcium gluconate market size was exhibited at USD 37.51 billion in 2023 and is expected to gain around USD 69.03 billion by 2033.
- North America dominated the market with the largest market share of 38% in 2023.
- Asia Pacific is witnessing rapid growth in the global market.
- By grade, the pharmaceutical grade segment has captured more than 64% of market share in 2023.
- By grade, the food grade segment is expected to grow the fastest over the projected period.
- By form, the powder segment has accounted more than 43% of market share in 2023.
- By form, the liquid segment is the fastest-growing segment during the forecast period.
- By function, the calcium supplement segment held the largest market share in 2023.
- By application, the food & beverages manufacturers segment dominated the market in 2023 and is expected to grow significantly till 2033.
The calcium gluconate market is experiencing steady growth globally, driven by its widespread applications across various industries. Calcium gluconate, a mineral supplement, is widely used in the pharmaceutical, food and beverage, cosmetics, and agriculture sectors. Its versatility and essential role in maintaining bone health, as well as its application in medical treatments for conditions like hypocalcemia, make it a sought-after product in the market.
Get a Sample: https://www.precedenceresearch.com/sample/4149
Growth Factors:
Several factors contribute to the growth of the calcium gluconate market. Increasing awareness about health and wellness, coupled with a growing aging population, drives the demand for calcium supplements. Moreover, the expanding pharmaceutical and food industries, particularly in emerging economies, further fuel the market growth. Additionally, advancements in production technologies and formulation techniques enhance the availability and effectiveness of calcium gluconate products, driving market expansion.
Region Insights:
The market for calcium gluconate exhibits a global presence, with key regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe lead the market due to the high prevalence of calcium deficiency disorders and the presence of established pharmaceutical and food industries. Meanwhile, the Asia Pacific region is witnessing rapid growth attributed to increasing healthcare expenditure, rising consumer awareness, and expanding food and beverage sectors.
Calcium Gluconate Market Scope
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 6.15% |
Global Market Size in 2023 | USD 98.72 Billion |
Global Market Size in 2024 | USD 104.79 Billion |
Global Market Size by 2033 | USD 179.31 Billion |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Grade, By Form, By Function, and By Application |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Calcium Gluconate Market Dynamics
Drivers:
Several drivers propel the growth of the calcium gluconate market. The rising incidence of calcium deficiency-related diseases, such as osteoporosis and hypocalcemia, stimulates demand for calcium supplements. Furthermore, the growing trend of preventive healthcare practices and dietary supplements contributes to market expansion. Additionally, government initiatives promoting calcium-enriched food products and supplements drive market growth in various regions.
Opportunities:
The calcium gluconate market presents promising opportunities for manufacturers and investors. Expansion into emerging markets with growing healthcare infrastructure and rising disposable incomes offers significant growth prospects. Moreover, research and development initiatives aimed at innovating new formulations and delivery methods present opportunities for product diversification and market penetration.
Challenges:
Despite the positive growth trajectory, the calcium gluconate market faces challenges such as regulatory hurdles related to product approval and safety standards. Additionally, fluctuations in raw material prices and supply chain disruptions pose challenges to market players. Moreover, competition from alternative calcium supplements and substitutes may hinder market growth to some extent.
Competitive Landscape:
The calcium gluconate market is characterized by intense competition among key players striving to gain a competitive edge through product innovation, strategic collaborations, and mergers and acquisitions. Leading companies in the market include Pfizer Inc., Global Calcium Private Limited, CalciTech Europe S.A., and AKHIL HEALTHCARE (P) LTD., among others. These players focus on expanding their product portfolios, enhancing distribution networks, and strengthening their presence in emerging markets to maintain their market position and capitalize on growth opportunities.
Read Also: Solar Encapsulation Market Size, Trends, Share, Report By 2033
Calcium Gluconate Market Recent Developments
- In May 2023, Kemira, a Finnish company that provides chemicals and services for the water, energy, and industrial markets, announced that it had acquired the calcium propionate business of Eastman Chemical Company. The acquisition is expected to strengthen Kemira’s position in the global calcium propionate market.
- In April 2023, Perstorp Chemicals Pvt. Ltd., an Indian manufacturer of specialty chemicals, announced that it had increased its production capacity for calcium propionate. The increase in capacity is expected to meet the growing demand for calcium propionate in India.
- In March 2023, Macco Organiques Inc., a Czech Republic-based manufacturer of food additives, announced that it had received approval from the US Food and Drug Administration (FDA) for its calcium product. The approval allows the company to sell its calcium propionate product in the United States.
Calcium Gluconate Market Companies
- Pfizer
- Novartis
- Amphastar
- Akorn
- West-Ward Pharmaceuticals
- Fresenius Kabi USA
- Merck
- Mylan Institutional LLC
- Grifols USA LLC
- Baxter International
Segments Covered in the Report
By Grade
- Pharmaceutical Grade
- Food Grade
By Form
- Liquid
- Tablet
- Powder
- Gel
By Function
- Calcium Supplement
- Bone Health
- Antacid
- Skincare and Cosmetics
By Application
- Pharmaceuticals
- Food & Beverages
- Nutraceuticals
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/